PILL.AR

Ninety-nine percent of prescriptions worldwide are based on commercial medications, designed with standardized doses and combinations for a nonexistent "average patient." As a consequence: 65% of older adults take more than five medications a day (polypharmacy). 50% of patients abandon or do not adhere to their treatments (low adherence). In cardiovascular or mental health treatments, 35% suffer preventable adverse effects. More than 2 million deaths annually and $42 billion in hospitalizations are due to medication errors. Although the need for personalized treatments is evident—and science increasingly shows us how different we are in genetics, microbiota, and metabolism—the system is not prepared to respond. There is a critical gap between what we can know about each patient and what the system can offer. Compound pharmacies, the only ones authorized to formulate customized medications, play a key role. But their impact remains marginal: their manual methods, high variability, and low scalability generate distrust among doctors and patients. In fact, they account for only 1% of prescriptions globally. PILL.AR was created to close that gap and transform the way medications are produced, prescribed, and consumed, right down to a single capsule.